247 related articles for article (PubMed ID: 22212142)
21. [Cutaneous marginal zone B-cell lymphoma treated with rituximab].
Pedraz J; Delgado Y; Aragüés M; Fraga J; García-Díez A; Fernández-Herrera J
Actas Dermosifiliogr; 2005 Nov; 96(9):593-7. PubMed ID: 16476304
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in primary cutaneous B-cell lymphomas.
Vermeer MH; Willemze R
Curr Opin Oncol; 2014 Mar; 26(2):230-6. PubMed ID: 24463347
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous lymphomas].
Ingen-Housz-Oro S; Bagot M
Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
Lima M
An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
[TBL] [Abstract][Full Text] [Related]
25. Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma.
Roguedas AM; Watier H; Paintaud G; de Muret A; Vaillant L; Machet L
Br J Dermatol; 2005 Mar; 152(3):541-4. PubMed ID: 15787825
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of different methods in the follow-up of patients with indolent types of primary cutaneous lymphomas.
Terhorst D; Mestel DS; Humme D; Sterry W; Beyer M
Br J Dermatol; 2012 Jun; 166(6):1295-300. PubMed ID: 22356095
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
28. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
Bonnekoh B; Schulz M; Franke I; Gollnick H
J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
[TBL] [Abstract][Full Text] [Related]
29. Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab.
Nagasaka A; Matsue H; Kawamura T; Kanzaki M; Inozume T; Nakamura Y; Shimzu A; Shibagaki N; Yanagi M; Shimada S
J Dermatol; 2006 May; 33(5):377-9. PubMed ID: 16700675
[No Abstract] [Full Text] [Related]
30. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
31. [Lymphomas of the skin].
Nagatani T; Baba N; Nakajima H
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1308-13. PubMed ID: 7688500
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous lymphomas.
Klemke CD
J Dtsch Dermatol Ges; 2014 Jan; 12(1):7-28; quiz 29-30. PubMed ID: 24393310
[TBL] [Abstract][Full Text] [Related]
34. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
Gamo R; Calzado L; Pinedo F; López-Estebaranz JL
Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
36. [Primary cutaneous B-cell lymphomas: study of 22 cases].
Martín Carrasco P; Morillo Andújar M; Pérez Ruiz C; de Zulueta Dorado T; Cabrera Pérez R; Conejo-Mir J
Med Clin (Barc); 2016 Sep; 147(5):207-210. PubMed ID: 27427313
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous large B-cell leg-type lymphoma occurring on a leg burn].
Meziane M; Hesse S; Chetaille B; Bien-Aimée A; Grob JJ; Richard MA
Ann Dermatol Venereol; 2009 Nov; 136(11):791-4. PubMed ID: 19917431
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
